(Q40487963)

21 September 2017

1 reference

title

Antiviral therapy in human immunodeficiency virus infections. Current status (Part II). (English)

1 reference

21 September 2017

E Sandström

1

1 reference

21 September 2017

B Oberg

series ordinal

2

1 reference

21 September 2017

publication date

1 May 1993

1 reference

21 September 2017

1 reference

21 September 2017

volume

45

1 reference

21 September 2017

issue

5

1 reference

21 September 2017

page(s)

637-653

1 reference

Experimental infection of cynomolgus monkeys (Macaca fascicularis) with HIV-2

21 September 2017

cites work

1 reference

12 December 2020

Prevention of HIV-2 and SIV infections in cynomolgus macaques by prophylactic treatment with 3'-fluorothymidine

1 reference

12 December 2020

Pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine in rhesus monkeys

1 reference

12 December 2020

Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children.

1 reference

12 December 2020

Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-1 (HIV-1)-infected men.

1 reference

12 December 2020

Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex.

1 reference

12 December 2020

Induction of Endogenous Virus and of Thymidine Kinase by Bromodeoxyuridine in Cell Cultures Transformed by Friend Virus

1 reference

12 December 2020

A soluble CD4 protein selectively inhibits HIV replication and syncytium formation

1 reference

12 December 2020

A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research

1 reference

12 December 2020

PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptase

1 reference

12 December 2020

Generation of nucleoside-resistant variants of HIV-1 by in vitro selection in the presence of AZT or DDI but no by combinations

1 reference

12 December 2020

The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group

1 reference

12 December 2020

Serum p24 antigen levels in untreated and zidovudine-treated HIV-1 infected subjects

1 reference

12 December 2020

Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera

1 reference

12 December 2020

Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis

1 reference

12 December 2020

Pharmacokinetics of foscarnet after twice-daily administrations for treatment of cytomegalovirus disease in AIDS patients

1 reference

12 December 2020

Declining levels of HIV P24 antigen in serum during treatment with foscarnet

1 reference

12 December 2020

Glucosidase inhibitors for treatment of HIV-1 infection

1 reference

12 December 2020

HIV infection is blocked in vitro by recombinant soluble CD4.

1 reference

12 December 2020

Antipsoriatic effects of zidovudine in human immunodeficiency virus-associated psoriasis

1 reference

12 December 2020

Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study

1 reference

12 December 2020

3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents

1 reference

12 December 2020

Comparison of in vitro biological properties and mouse toxicities of three thymidine analogs active against human immunodeficiency virus

1 reference

12 December 2020

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

1 reference

12 December 2020

Pharmacokinetics of R 82913 in patients with AIDS or AIDS-related complex

1 reference

12 December 2020

HIV-1 replication and potential targets for intervention

1 reference

12 December 2020

The combined toxicity of azidothymidine and antimycobacterial agents. A retrospective study

1 reference

12 December 2020

Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture

1 reference

12 December 2020

Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor

1 reference

12 December 2020

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

1 reference

12 December 2020

Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects

1 reference

12 December 2020

Remarkable improvement of neuropsychiatric symptoms in HIV-infected patients after AZT therapy

1 reference

12 December 2020

A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site

1 reference

12 December 2020

Enhanced in vitro inhibition of HIV-1 replication by 3'-fluoro-3'-deoxythymidine compared to several other nucleoside analogs

1 reference

12 December 2020

Antiviral activity of 2',3'-dideoxycytidin-2'-ene (2',3'-dideoxy-2',3'-didehydrocytidine) against human immunodeficiency virus in vitro

1 reference

12 December 2020

The new AIDS case definition. Implications for San Francisco

1 reference

12 December 2020

3'-Deoxy-3'-fluorothymidine, a new selective inhibitor of DNA-synthesis

1 reference

12 December 2020

Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine

1 reference

12 December 2020

Three-drug synergistic inhibition of HIV-1 replication in vitro by 3'-fluoro-3'-deoxythymidine, recombinant soluble CD4, and recombinant interferon-alpha

1 reference

12 December 2020

Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacokinetics of stavudine in patients with AIDS or AIDS-related complex

1 reference

12 December 2020

A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group

1 reference

12 December 2020

Azidothymidine-induced nail pigmentation

1 reference

12 December 2020

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

1 reference

12 December 2020

Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

1 reference

12 December 2020

Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study

1 reference

12 December 2020

Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complex

1 reference

12 December 2020

The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals

1 reference

12 December 2020

The biochemistry of AIDS.

1 reference

12 December 2020

Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. Italian Zidovudine Evaluation Group

1 reference

12 December 2020

Review of the toxicities of foscarnet

1 reference

12 December 2020

Effect of probenecid on the renal and nonrenal clearances of zidovudine and its distribution into cerebrospinal fluid in the rabbit

1 reference

12 December 2020

Probenecid enhances central nervous system uptake of 2',3'-dideoxyinosine by inhibiting cerebrospinal fluid efflux.

1 reference

12 December 2020

Pharmacokinetics of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in patients with severe human immunodeficiency virus infection

1 reference

12 December 2020

The effect of zidovudine on platelet count in HIV-infected individuals

1 reference

12 December 2020

Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase

1 reference

12 December 2020

Loss of synergistic response to combinations containing AZT in AZT-resistant HIV-1.

1 reference

12 December 2020

Penetration of zidovudine and 3'-fluoro-3'-deoxythymidine into the brain, muscle tissue, and veins in cynomolgus monkeys: relation to antiviral action

1 reference

12 December 2020

L-696,229 specifically inhibits human immunodeficiency virus type 1 reverse transcriptase and possesses antiviral activity in vitro

1 reference

12 December 2020

Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase II AZT placebo-controlled study: San Diego cohort

1 reference

12 December 2020

HIV protease: a novel chemotherapeutic target for AIDS.

1 reference

12 December 2020

Cytomegalovirus viremia in HIV-infected patients treated with zidovudine

1 reference

12 December 2020

Antiretroviral therapy: reverse transcriptase inhibition

1 reference

12 December 2020

Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition

1 reference

12 December 2020

Antiviral effects of phosphonoformate (PFA, foscarnet sodium).

1 reference

12 December 2020

Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases

1 reference

12 December 2020

Didanosine. A review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection

1 reference

12 December 2020

Infection of the SCID-hu mouse by HIV-1

1 reference

12 December 2020

Antiviral therapy in human immunodeficiency virus infection

1 reference

12 December 2020

Toxicology and pharmacology of adenine in animals and man

1 reference

12 December 2020

Analytical method for the quantification of 2',3'-didehydro-3'-deoxythymidine, a new anti-human immunodeficiency virus (HIV) agent, by high-performance liquid chromatography (HPLC) and ultraviolet (UV) detection in rat and monkey plasma

1 reference

12 December 2020

Inhibition of HTLV-III/LAV replication by foscarnet

1 reference

12 December 2020

The effects on survival of early treatment of human immunodeficiency virus infection

1 reference

12 December 2020

Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors

1 reference

12 December 2020

Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis

1 reference

12 December 2020

Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial

1 reference

12 December 2020

Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist

1 reference

12 December 2020

Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides

1 reference

12 December 2020

Nonnucleoside inhibitors of HIV-1 reverse transcriptase: nevirapine as a prototype drug

1 reference

12 December 2020

Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet

1 reference

12 December 2020

Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone

1 reference

12 December 2020

Declining incidence of AIDS dementia complex after introduction of zidovudine treatment

1 reference

12 December 2020

Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.

1 reference

12 December 2020

Fetoplacental passage of 2',3'-dideoxyinosine

1 reference

12 December 2020

Azidothymidine-induced hyperpigmentation mimicking primary adrenal insufficiency

1 reference

12 December 2020

Susceptibility to nucleoside analogues of zidovudine-resistant isolates of human immunodeficiency virus

1 reference

12 December 2020

The safety of intravenous chemotherapy and zidovudine when treating epidemic Kaposi's sarcoma

1 reference

12 December 2020

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex

1 reference

12 December 2020

The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.

1 reference

12 December 2020

Disposition in animals of a new anti-HIV agent: 2',3'-didehydro-3'-deoxythymidine

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor in human immunodeficiency virus disease

1 reference

12 December 2020

AZT inhibits HIV-1 replication in monocytes

1 reference

12 December 2020

Reverse transcriptases from human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus (SIVMAC) are susceptible to inhibition by foscarnet and 3'-azido-3'-deoxythymidine triphosphate

1 reference

12 December 2020

Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex

1 reference

12 December 2020

The effect of foscarnet (phosphonoformate) on human immunodeficiency virus isolation, T-cell subsets and lymphocyte function in AIDS patients.

1 reference

12 December 2020

Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon

1 reference

12 December 2020

Human immunodeficiency virus structure: implications for antiviral design.

1 reference

12 December 2020

(-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro

1 reference

12 December 2020

Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1

1 reference

12 December 2020

The HIV-1 protease as a therapeutic target for AIDS

1 reference

12 December 2020

Effect of zidovudine on survival of patients with AIDS in Australia

1 reference

12 December 2020

Early predictors of survival in symptomatic HIV-infected persons treated with high-dose zidovudine

1 reference

12 December 2020

Insights into HIV chemotherapy

1 reference

12 December 2020

Pharmacokinetics of concomitantly administered foscarnet and zidovudine for treatment of human immunodeficiency virus infection (AIDS Clinical Trials Group protocol 053)

1 reference

12 December 2020

Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection

1 reference

12 December 2020

Prevention of HIV-1 IIIB infection in chimpanzees by CD4 immunoadhesin

1 reference

12 December 2020

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).

1 reference

12 December 2020

Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate

1 reference

12 December 2020

Probenecid and zidovudine metabolism

1 reference

12 December 2020

Inhibition of HIV-replication by 3'-fluoro-modified nucleosides with low cytotoxicity

1 reference

12 December 2020

Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages

1 reference

12 December 2020

Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog

1 reference

12 December 2020

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

1 reference

12 December 2020

Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay

1 reference

12 December 2020

Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial

1 reference

12 December 2020

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates

1 reference

12 December 2020

Phosphonoformate Inhibits Reverse Transcriptase

1 reference

12 December 2020

Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date

1 reference

12 December 2020

A pilot study of low-dose zidovudine in human immunodeficiency virus infection

1 reference

12 December 2020

Frontiers in HIV-1 Therapy: fourth conference of the NIAID National Cooperative Drug Discovery Groups-HIV

1 reference

12 December 2020

Response of AIDS-related thrombocytopenia to intravenous and oral azidothymidine (3'-azido-3'-deoxythymidine).

1 reference

12 December 2020

Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex

1 reference

12 December 2020

Computer-assisted structure-activity correlations of halodideoxynucleoside analogs as potential anti-HIV drugs

1 reference

12 December 2020

An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives

1 reference

12 December 2020

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

1 reference

12 December 2020

1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent

1 reference

12 December 2020

2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial

1 reference

12 December 2020

Synergistic Inhibition of Human Immunodeficiency Virus Replication In Vitro by Combinations of 3′-Azido-3′-Deoxythymidine and 3′-Fluoro-3′-Deoxythymidine

1 reference

12 December 2020

Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1

1 reference

12 December 2020

In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease

1 reference

12 December 2020

Concentrations of phosphorylated zidovudine (ZDV) in patient leukocytes do not correlate with ZDV dose or plasma concentrations

1 reference

12 December 2020

The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro

1 reference

12 December 2020

Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen

1 reference

12 December 2020

HIV regulatory proteins: potential targets for therapeutic intervention

1 reference

12 December 2020

Regression of cytomegalovirus retinitis with zidovudine. A clinicopathologic correlation

1 reference

12 December 2020

Acute pancreatitis as a common complication of 2',3'-dideoxyinosine therapy in the acquired immunodeficiency syndrome

1 reference

12 December 2020

A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templates

1 reference

12 December 2020

Cellular pharmacology of 2',3'-dideoxy-2',3'-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus

1 reference

12 December 2020

Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study

1 reference

12 December 2020

One-year follow-up on the safety and efficacy of isoprinosine for human immunodeficiency virus infection. Scandinavian Isoprinosine Study Group

1 reference

12 December 2020

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2',3'-dideoxycytidine

1 reference

12 December 2020

Genetic regulation of human immunodeficiency virus.

1 reference

12 December 2020

Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication

1 reference

12 December 2020

Cellular metabolism of 2',3'-dideoxycytidine, a compound active against human immunodeficiency virus in vitro

1 reference

12 December 2020

Blocking of human immunodeficiency virus infection depends on cell density and viral stock age

1 reference

12 December 2020

A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group

1 reference

12 December 2020

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

1 reference

12 December 2020

Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.

1 reference

12 December 2020

Phosphorylation, anti-HIV activity and cytotoxicity of 3'-fluorothymidine

1 reference

12 December 2020

Antiviral effects of 3'-fluorothymidine and 3'-azidothymidine in cynomolgus monkeys infected with simian immunodeficiency virus

1 reference

12 December 2020

Zalcitabine. A review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS)

1 reference

12 December 2020

Ribavirin antagonizes the effect of azidothymidine on HIV replication

1 reference

12 December 2020

The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function

1 reference

12 December 2020

3'-Deoxy-3'-fluorothymidinetriphosphate: inhibitor and terminator of DNA synthesis catalysed by DNA polymerase beta, terminal deoxynucleotidyl transferase and DNA polymerase I.

1 reference

12 December 2020

Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of cytomegalovirus retinitis with zidovudine and ganciclovir in patients with AIDS: outcome and toxicity

1 reference

12 December 2020

Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity

1 reference

12 December 2020

RNA complementary to herpes simplex virus type 1 ICP0 gene demonstrated in neurons of human trigeminal ganglia

1 reference

12 December 2020

In vitro bone marrow toxicity of nucleoside analogs against human immunodeficiency virus

1 reference

12 December 2020

The spectrum of pancreatic disorders in patients with the acquired immune deficiency syndrome.

1 reference

12 December 2020

Fidelity of HIV-1 reverse transcriptase

1 reference

12 December 2020

Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA.

1 reference

12 December 2020

Double blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group

1 reference

12 December 2020

An analysis of the inhibition of replication of HIV and MuLV by some 3'-blocked pyrimidine analogs

1 reference

12 December 2020

A soluble form of CD4 (T4) protein inhibits AIDS virus infection

1 reference

12 December 2020

Fetoplacental passage of zidovudine

1 reference

12 December 2020

A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study

1 reference

12 December 2020

Basic approaches to anti-retroviral treatment

1 reference

12 December 2020

In Vivo Additive Antiretroviral Effect of Combined Zidovudine and Foscarnet Therapy for Human Immunodeficiency Virus Infection (ACTG Protocol 053)

1 reference

12 December 2020

Treatment of epidemic Kaposi's sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudine

1 reference

12 December 2020

Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides

1 reference

12 December 2020

Susceptibility of phosphonoformic acid-resistant herpes simplex virus variants to arabinosylnucleosides and aphidicolin

1 reference

12 December 2020

Prospects for the control of AIDS by immunizing seropositive individuals

1 reference

12 December 2020

Long-term administration of 3'-azido-2',3'-dideoxythymidine to patients with AIDS-related neurological disease

1 reference

12 December 2020

HIV inhibitors targeted at the reverse transcriptase

1 reference

12 December 2020

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

1 reference

12 December 2020

The National Cancer Institute phase I study of 2',3'-dideoxyinosine administration in adults with AIDS or AIDS-related complex: analysis of activity and toxicity profiles

1 reference

12 December 2020

Human immunodeficiency virus reverse transcriptase. General properties and its interactions with nucleoside triphosphate analogs

1 reference

12 December 2020

Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cells

1 reference

12 December 2020

Effect of isoprinosine on HIV antigenaemia

1 reference

12 December 2020

Anti-retrovirus activity of 3'-fluoro- and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside analogues

1 reference

12 December 2020

Mitochondrial myopathy caused by long-term zidovudine therapy

1 reference

12 December 2020

Phase 1 study of recombinant human CD4-immunoglobulin G therapy of patients with AIDS and AIDS-related complex

1 reference

12 December 2020

Effects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gamma

1 reference

12 December 2020

Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus

1 reference

12 December 2020

Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study

1 reference

12 December 2020

Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group

1 reference

12 December 2020

10.2165/00003495-199345050-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

21 September 2017

1018334298

0 references

1 reference